The Fragile X Family of Disorders: A Model for Autism and Targeted Treatments
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
CGG-repeat expansion mutations of the fragile X mental retardation 1 (FMR1) gene are the leading known cause of autism and autism spectrum disorders (ASD). Full mutation expansions ( > 200 CGG repeats) of the gene are generally silenced, resulting in absence of the FMR1 protein and fragile X syndrome. By contrast, smaller expansions in the premutation range (55-200 CGG repeats) result in excess gene activity and RNA toxicity, which is responsible for the neurodegenerative disorder, fragile X-associated tremor/ataxia syndrome (FXTAS), and likely additional cases of developmental delay and autism. Thus, the FMR1 gene is causative of a common (autism) phenotype via two entirely different pathogenic mechanisms, RNA toxicity and gene silencing. The study of this gene and its pathogenic mechanisms therefore represents a paradigm for understanding gene-brain relationships and the means by which diverse genetic mechanisms can give rise to a common behavioral phenotype. Keywords: fragile X mental retardation 1 gene, Idiopathic Autism, methyl-CpG binding protein, Neuroimaging, CGG repeat
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 1×
“Recent studies in autism also demonstrate enhanced inflammation in the brain that likely interferes with CNS connectivity leading to autism [166].”
BackgroundDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602 · cited 1×
“SHANK3 encodes a synaptic protein that is critical for proper brain development; point mutations of this gene cause ASD [21, 24].”
BackgroundThe mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · cited 4×
“The enhanced LTD was mediated by the mGluR5 pathway and FMRP normally inhibits the translation of proteins that internalize the AMPA receptors at the synapse, leading to LTD or weakening of synaptic connections [10].”
BackgroundInfluentialAltered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · cited 2×
“[103] demonstrated enhanced long term depression (LTD) in the hippocampus of the KO mouse model of FXS.”
BackgroundBaron-Cohen, S., Ring, H. A., Bullmore, E. T., Wheelwright, S., Ashwin, C., & Williams, S. C. R. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00011-7 · Cited by 1,130
mRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062 · cited 6×
“Recent studies in autism also demonstrate enhanced inflammation in the brain that likely interferes with CNS connectivity leading to autism [166].”
BackgroundInfluentialFMR1 and the fragile X syndrome: Human genome epidemiology review
Crawford, D. C., Acuña, J. M., & Sherman, S. L. (2001) · Genetics in Medicine · doi:10.1097/00125817-200109000-00006 · Cited by 711 · cited 1×
“The prevalence of FXS with mental retardation is approximately 1 per 3,600 males in the general population; however, females with FXS usually present with learning disabilities [36-39].”
BackgroundRogers, S. J., & Ozonoff, S. (2005) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2005.01431.x · Cited by 597 · cited 1×
“A subgroup of individuals with idiopathic autism also have enhanced sensory modulation problems [64, 65]; therefore, FXS represents a useful model for this subtype of autism.”
BackgroundSearching for ways out of the autism maze: genetic, epigenetic and environmental clues
Persico, A. M., & Bourgeron, T. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.010 · Cited by 575
Visual recognition of biological motion is impaired in children with autism
Blake, R., Turner, L. M., Smoski, M. J., Pozdol, S. L., & Stone, W. L. (2003) · Psychological Science · doi:10.1111/1467-9280.01434 · Cited by 571 · cited 1×
“nonperson judgment) was found to be impaired in autism, and correlated strongly with autistic symptomology [99].”
BackgroundSuppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP
Yan, Q. J., Rammal, M., Tranfaglia, M., & Bauchwitz, R. P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.004 · Cited by 521 · cited 1×
“The study of the mGluR5 antagonist, MPEP, in the KO mouse model of FXS has led to a decrease in seizures and some improvement in cognition [116].”
BackgroundRNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice
Miyashiro, K. Y., Beckel-Mitchener, A., Purk, T. P., Becker, K. G., Barret, T., Liu, L., Carbonetto, S., Weiler, I. J., Greenough, W. T., & Eberwine, J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00034-5 · Cited by 495
From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome
Bagni, C., & Greenough, W. T. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1667 · Cited by 475 · cited 2×
“In this regard, one of the key proteins for translating environmental stimuli to changes in synaptic structure is the FMR1 protein (FMRP) that is deficient or missing in fragile X syndrome [34, 35].”
BackgroundEvidence for a cerebellar role in reduced exploration and stereotyped behavior in autism
Pierce, K., & Courchesne, E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01008-8 · Cited by 464 · cited 1×
“variability within the autism group, one of the features that emerges most clearly is the presence of reduced volume of cerebellar hemispheres and vermal lobules [84-87] – findings consistent with those observed in FXS.”
ResultMotion processing in autism: evidence for a dorsal stream deficiency
Spencer, J., OʼBrien, J., Riggs, K., Braddick, O., Atkinson, J., & Wattam-Bell, J. (2000) · Neuroreport · doi:10.1097/00001756-200008210-00031 · Cited by 402
Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome
Hinds, H. L., Ashley, C. T., Sutcliffe, J. S., Nelson, D. L., Warren, S. T., Housman, D. E., & Schalling, M. (1993) · Nature Genetics · doi:10.1038/ng0193-36 · Cited by 396
Autistic behavior in children with fragile X syndrome: Prevalence, stability, and the impact of FMRP
Hatton, D. D., Sideris, J., Skinner, M., Mankowski, J., Bailey, D. B., Roberts, J., & Mirrett, P. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31286 · Cited by 359 · cited 3×
“These disorders include fragile X syndrome [FXS, 1], fragile X-associated tremor/ataxia syndrome [FXTAS, 2, 3], fragile X-associated premature ovarian failure [FXPOF, 4], and psychiatric problems including autism and autism spectrum disorders (ASD) associated with both the premutation and the full mutation [5-9].”
BackgroundVorstman, J. A. S., Staal, W. G., van Daalen, E., van Engeland, H., Hochstenbach, P. F. R., & Franke, L. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001757 · Cited by 353 · cited 1×
“[22].”
Sensorimotor gating deficits in adults with autism
Perry, W., Minassian, A., Lopez, B., Maron, L., & Lincoln, A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.025 · Cited by 352 · cited 1×
“The PPI deficits have also been seen in patients with autism who do not have FXS [68].”
BackgroundFARZIN, F., PERRY, H., HESSL, D., LOESCH, D., COHEN, J., BACALMAN, S., GANE, L., TASSONE, F., HAGERMAN, P., & HAGERMAN, R. (2006) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200604002-00012 · Cited by 325 · cited 7×
“The proband boys with the premutation had a high rate of ADHD (93”
BackgroundInfluentialSelf-citationDecreased expression of the GABAA receptor in fragile X syndrome
D'Hulst, C., De Geest, N., Reeve, S. P., Van Dam, D., De Deyn, P. P., Hassan, B. A., & Kooy, R. F. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.115 · Cited by 318 · cited 6×
“The PPI deficit in FXS demonstrates an inhibitory deficit frontally and may be related to GABA deficits that have been documented in the knock out (KO) mouse model of FXS [11, 67].”
BackgroundInfluentialPorter, R. H. P., Jaeschke, G., Spooren, W., Ballard, T. M., Büttelmann, B., Kolczewski, S., Peters, J.-U., Prinssen, E., Wichmann, J., Vieira, E., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089839 · Cited by 308
Motion Perception in Autism: A “Complex” Issue
Bertone, A., Mottron, L., Jelenic, P., & Faubert, J. (2003) · Journal of Cognitive Neuroscience · doi:10.1162/089892903321208150 · Cited by 306
Dombrowski, C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.4.371 · Cited by 289 · cited 1×
“The prevalence of the premutation range of 55 to 200 CGG repeats is approximately 1 per 130-260 females and 1 per 300-800 males in the general population [41-43].”
BackgroundSensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.
Frankland, P. W., Wang, Y., Rosner, B., Shimizu, T., Balleine, B. W., Dykens, E. M., Ornitz, E. M., & Silva, A. J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001432 · Cited by 275 · cited 1×
“Recent studies of prepulse inhibition (PPI), a measure of frontal gating, have demonstrated deficits in PPI in children with FXS compared to controls [66].”
ResultEpilepsy in fragile X syndrome
Berry‐Kravis, E. (2002) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2002.tb00277.x · Cited by 271
The fra(X) syndrome: Neurological, electrophysiological, and neuropathological abnormalities
Wisniewski, K. E., Segan, S. M., Miezejeski, C. M., Sersen, E. A., & Rudelli, R. D. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320380267 · Cited by 261 · cited 1×
“[73] reported that the seizures usually occurred in childhood, although seizures may also occur in adulthood [74].”
BackgroundNeurodevelopmental effects of the FMR-1 full mutation in humans
Reiss, A. L., Abrams, M. T., Greenlaw, R., Freund, L., & Denckla, M. B. (1995) · Nature Medicine · doi:10.1038/nm0295-159 · Cited by 242
Cytogenetic abnormalities and fragile-x syndrome in Autism Spectrum Disorder
Reddy, K. S. (2005) · BMC Medical Genetics · doi:10.1186/1471-2350-6-3 · Cited by 222 · cited 1×
“Whereas in the past decade we could identify approximately 10-15% of the underlying causes of autism [16, 17], more recent studies have increased this percentage to 20-41% in those instances where a thorough genetic workup includes sophisticated metabolic and molecular studies [15, 18-20].”
BackgroundPursuit eye movement deficits in autism
Takarae, Y. (2004) · Brain · doi:10.1093/brain/awh307 · Cited by 193 · cited 1×
“Another line of research that supports a dorsal stream deficit hypothesis in autism is the finding of deficits in smooth pursuit eye movements [100], which in schizophreN t For Distr ibu i”
BackgroundThe Prader-Willi phenotype of fragile X syndrome
Nowicki, S. T., Tassone, F., Ono, M. Y., Ferranti, J., Croquette, M. F., Goodlin-Jones, B., & Hagerman, R. J. (2007) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/01.dbp.0000267563.18952.c9 · Cited by 174
Self-citationThe neuroanatomy and neuroendocrinology of fragile X syndrome
Hessl, D., Rivera, S. M., & Reiss, A. L. (2004) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20004 · Cited by 165
Self-citationSamaco, R. C. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh063 · Cited by 163 · cited 1×
“[28] studied the brains of children and adults who had died with autism and found significantly lowered expression of MeCP2 compared to control brains.”
BackgroundChromosomal abnormalities in a clinic sample of individuals with autistic disorder
Wassink, T. H., Piven, J., & Patil, S. R. (2001) · Psychiatric Genetics · doi:10.1097/00041444-200106000-00001 · Cited by 157
Therapeutic implications of the mGluR theory of fragile X mental retardation
Bear, M. F. (2005) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00135.x · Cited by 137 · cited 1×
“The metabotropic glutamate receptor 5 (mGluR5) antagonists also represent potential therapeutic agents for individuals with FXS [115].”
Background
Cited by
Advances in the Treatment of Fragile X Syndrome
Hagerman, R. J., Berry-Kravis, E., Kaufmann, W. E., Ono, M. Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C., Hessl, D., Visootsak, J., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-0317 · Cited by 596
Self-citationAutism spectrum disorders-a genetics review
Miles, J. H. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3181ff67ba · Cited by 567
The fragile X prevalence paradox
Hagerman, P. J. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.059055 · Cited by 342
Self-citationFragile X: Leading the Way for Targeted Treatments in Autism
Wang, L. W., Berry-Kravis, E., & Hagerman, R. J. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.005 · Cited by 176
Self-citationAdvances in understanding the molecular basis of FXTAS
Garcia-Arocena, D., & Hagerman, P. J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq166 · Cited by 136
“Absence of the protein leads to fragile X syndrome, a neurodevelopmental disorder and the leading monogenic form of cognitive-impairment and autism (10,15,16).”
BackgroundSelf-citation
Metadata
- Authors
- Hagerman, R., Rivera, S., & Hagerman, P.
- Venue
- Current Pediatric Reviews
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-02-01
- Volume
- 4
- Issue
- 1
- Pages
- 40-52
- ISSN
- 1573-3963 (ISSN-L)
- OpenAlex
- W2118414253
- Cited by
- 100
- References
- 35
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.